Package 67457-645-02

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67457-645-02
Digits Only 6745764502
Product NDC 67457-645
Description

10 VIAL, SINGLE-DOSE in 1 CARTON (67457-645-02) / 1 mL in 1 VIAL, SINGLE-DOSE (67457-645-00)

Marketing

Marketing Status
Marketed Since 2020-01-24
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ae19fec7-aac8-4fbe-a2aa-ba18a3fe5c9e", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["5adbf891-4d73-4026-98b1-174783d68c9a"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (67457-645-02)  / 1 mL in 1 VIAL, SINGLE-DOSE (67457-645-00)", "package_ndc": "67457-645-02", "marketing_start_date": "20200124"}], "brand_name": "Naloxone Hydrochloride", "product_id": "67457-645_ae19fec7-aac8-4fbe-a2aa-ba18a3fe5c9e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "67457-645", "generic_name": "naloxone hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA204997", "marketing_category": "ANDA", "marketing_start_date": "20200124", "listing_expiration_date": "20261231"}